Equity Overview
Price & Market Data
Price: $0.11
Daily Change: +$0.02 / 18.18%
Daily Range: $0.11 - $0.11
Market Cap: $75,749,152
Daily Volume: 9,000
Performance Metrics
1 Week: 22.22%
1 Month: 22.22%
3 Months: 60.35%
6 Months: 10.00%
1 Year: 10.00%
YTD: %
Details
Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.